乳がん を 克服 し た 人 たち の 中 で の パーキンソン病 の リスク: 韓国 の 全国 コーホート 研究
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。乳がんの生存者は一般的にパーキンソン病 (PD) のリスクが高くありません. しかし,より若い生存者は,PDのリスクが時間とともに増加し,神経変性リスクのさらなる調査を正当化します.
科学分野
- 腫瘍学
- 神経学
- 流行病学について
背景
- パーキンソン病 (PD) と乳がんは公衆衛生上の大きな問題です.
- 乳がんとPDリスクとの潜在的な関連に関する研究は限られている.
研究 の 目的
- 韓国 の 乳がん の 生存 者 の 中 で パーキンソン病 (PD) の 発症 リスク を 調査 する.
- 乳がんの生存者の年齢特有のPDリスク傾向を分析する.
主な方法
- 71,924人の乳がん生存者とマッチングした対照群の韓国国民健康保険サービスデータ (2010年−2016年) を利用した.
- PDのサブディストリビューションハザード比率 (sHRs) を計算するために,遅延分析を伴う競合するリスクモデルを使用した.
- PDのリスクを評価するために社会統計学的要因と併発性により調整された.
主要な成果
- 乳がんの生存者において,PDリスクの全体的な有意な増加は観察されなかった (sHR 0. 91).
- 年齢が50歳未満の生存者は,PDリスクが増加する傾向を示した (例えば,5年遅れでsHRは1. 49).
- 癌治療 (化学療法,内分泌療法,放射線治療) はPDリスクの上昇と関連していません.
結論
- 乳がんの生存者は集団として パーキンソン病のリスクが 大きく上昇しているわけではありません
- 年齢に関係するPDリスクの増加は,乳がんの若い生存者におけるさらなる研究を正当化しています.
関連する概念動画
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Tumors may result in a case where two people have the same mutations in an oncogene or tumor...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...